4.5 Article

Characteristics, Treatments, and Outcomes of Hospitalized Heart Failure Patients Stratified by Etiologies of Cardiomyopathy

期刊

JACC-HEART FAILURE
卷 3, 期 11, 页码 906-916

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.jchf.2015.06.012

关键词

HF etiology; ischemic cardiomyopathy; nonischemic cardiomyopathy; outcome

资金

  1. Council on Clinical Cardiology
  2. Stroke Council
  3. Council on Quality of Care and Outcomes Research
  4. Medtronic
  5. GlaxoSmithKline
  6. Ortho-McNeil
  7. American Heart Association Pharmaceutical Roundtable
  8. Amarin
  9. AstraZeneca
  10. Bristol-Myers Squibb
  11. Eisai
  12. Ethicon
  13. Forest Laboratories
  14. Ischemix
  15. Pfizer
  16. Roche
  17. Sanofi
  18. Medicines Company
  19. Janssen
  20. Novartis
  21. Portola
  22. Amgen
  23. Merck
  24. Gambro
  25. National Heart, Lung, and Blood Institute
  26. National Institutes of Health/National Institute of Allergy and Infectious Diseases

向作者/读者索取更多资源

OBJECTIVES The authors sought to describe characteristics, treatments, and in-hospital outcomes of hospitalized heart failure (HF) patients stratified by etiology. BACKGROUND Whether characteristics and outcomes of HF patients differ by cardiomyopathy etiology is unknown. METHODS The authors analyzed data on 156,013 hospitalized HF patients from 319 U. S. hospitals participating in Get With The Guidelines-HF between 2005 and 2013. Characteristics, treatments, and in-hospital outcomes were assessed by HF etiology. Standard regression techniques adjusted for site and patient-level characteristics were used to examine association between HF etiology and in-hospital outcomes. RESULTS Median age was 75 years, 69.2% were white, and 49.5% were women. Overall, 92,361 patients (59.2%) had ischemic cardiomyopathy and 63,652 patients (40.8%) had nonischemic cardiomyopathy (NICM). Hypertensive (n = 28,141; 48.5%) and idiopathic (n = 17,808; 30.7%) cardiomyopathies accounted for the vast majority of NICM patients. Post-partum (n = 209; 0.4%), viral (n = 447; 0.8%), chemotherapy (n = 721; 1.2%), substance abuse (n = 2,653; 4.6%), familial (n = 556; 1.0%), and other (n = 7,523; 13.0%) etiologies were far less frequent. There were significant differences in baseline characteristics between those with ischemic cardiomyopathy compared with NICM with respect to age (76 years vs. 72 years), sex (44.4% vs. 56.9% women), and ejection fraction (38% vs. 45%). Risk-adjusted quality of care provided to eligible patients varied minimally by etiology. Similarly, in-hospital mortality did not differ among ischemic compared with NICM patients. However, among NICM patients, only hypertensive cardiomyopathy had a lower mortality rate compared with idiopathic NICM (adjusted odds ratio: 0.83; 95% confidence interval: 0.71 to 0.97). CONCLUSIONS Characteristics of hospitalized HF patients vary by etiology. Both risk-adjusted quality of care and inhospital outcomes did not differ by etiology. (C) 2015 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据